Charity News from Wednesday, Sep. 24, 2003Genes can individualize treatment for high blood pressureAmerican Heart Association | Genes that cause hypertension may also determine which blood pressure-lowering drugs are most effective for different people, according to research presented today by the American Heart Association. Report Reveals Government Routinely Ignores Violations of Animal Welfare Act by Ringling Bros. American Society for the Prevention of Cruelty to Animals | Three of the nation's largest and oldest animal protection organizations have released an in-depth report revealing how the USDA routinely looks the other way when Ringling Bros. and Barnum & Bailey beats and mistreats elephants in its circus. Young Friends of the ASPCA to Host Fifth Annual Fundraiser 'Diamonds in the Ruff' to Benefit Animals in Need American Society for the Prevention of Cruelty to Animals | The Young Friends of the ASPCA hosts 'Diamonds in the Ruff,' a fundraiser to benefit The American Society for the Prevention of Cruelty to Animals (ASPCA) on Thursday, September 25, 2003 at Tiffany & Co.'s flagship store. Most adult survivors of childhood cancer consider themselves in good health St. Jude Children's Research Hospital (ALSAC) | Adult survivors of childhood cancer generally consider themselves to be in good health, even though more than 40 percent of such survivors indicated that at least one aspect of their health has been affected by the disease. Mexicans Struggle in Aftermath of Hurricanes Marty, Ignacio Catholic Relief Services | Catholic Relief Services is responding to the call of Catholic church partners in Mexico to assist in recovery efforts across a country battered by weeks of storms. For the second time in a month, northwestern Mexico was hard hit. Alzheimer's Association Encouraged by U.S. FDA Advisory Committee Recommendation of Approval for Memantine Alzheimer's Association | The Alzheimer's Association is encouraged by the recommendations of an advisory committee to the U.S. Food and Drug Administration (FDA) to approve memantine as a potential treatment for moderate to severe Alzheimer's disease (AD).
|
|
